[Topical immunomodulators, such as tacrolimus and pimecrolimus, in the treatment of atopic dermatitis].
van der Laan
J R
JR
D003876:Dermatitis, Atopic / Q000188:drug therapy; D003879:Dermatologic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D009369:Neoplasms / Q000139:chemically induced; D016559:Tacrolimus / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; D016559:Tacrolimus